Royal Bank Of Canada Ultragenyx Pharmaceutical Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 66,130 shares of RARE stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,130
Previous 4,678 1313.64%
Holding current value
$2.82 Million
Previous $192,000 1813.02%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.21 - $59.36 $2.47 Million - $3.65 Million
61,452 Added 1313.64%
66,130 $3.67 Million
Q2 2024

Aug 14, 2024
SELL
$37.42 - $51.61 $79,330 - $109,413
-2,120 Reduced 31.19%
4,678 $192,000
Q1 2024

Nov 05, 2024
BUY
$43.02 - $53.69 $91,202 - $113,822
2,120 Added 45.32%
6,798 $317,000
Q1 2024

May 15, 2024
SELL
$43.02 - $53.69 $1.14 Million - $1.42 Million
-26,449 Reduced 79.55%
6,798 $317,000
Q4 2023

Feb 14, 2024
SELL
$31.73 - $49.19 $79,388 - $123,073
-2,502 Reduced 7.0%
33,247 $1.59 Million
Q3 2023

Nov 14, 2023
SELL
$34.92 - $46.66 $732,831 - $979,206
-20,986 Reduced 36.99%
35,749 $1.27 Million
Q2 2023

Aug 14, 2023
SELL
$37.35 - $52.15 $1,606 - $2,242
-43 Reduced 0.08%
56,735 $2.62 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $1.94 Million - $2.56 Million
52,528 Added 1235.95%
56,778 $2.28 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $16,522 - $22,701
490 Added 13.03%
4,250 $196,000
Q3 2022

Nov 14, 2022
SELL
$39.96 - $66.14 $123,556 - $204,504
-3,092 Reduced 45.13%
3,760 $155,000
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $18,274 - $34,074
-399 Reduced 5.5%
6,852 $410,000
Q1 2022

May 16, 2022
SELL
$62.2 - $84.4 $91,807 - $124,574
-1,476 Reduced 16.91%
7,251 $526,000
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $54,471 - $64,928
739 Added 9.25%
8,727 $734,000
Q3 2021

Nov 15, 2021
SELL
$77.92 - $102.4 $1.87 Million - $2.46 Million
-24,018 Reduced 75.04%
7,988 $719,000
Q2 2021

Aug 16, 2021
BUY
$92.19 - $115.71 $2.95 Million - $3.7 Million
32,006 New
32,006 $3.05 Million

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.99B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email